Navigation Links
Patient Pain Management at a Glance
Date:4/12/2017

TORONTO, April 12, 2017 /PRNewswire/ -- Intronix Technologies will be launching "Myoguide DOC", a comprehensive software package designed to help clinicians who inject Botulinum Toxins, such as Botox®, Dysport® and Xeomin® to manage their patient's spasticity and pain.

Myoguide DOC is the first integrated graphics driven patient management system that helps clinicians to document all aspects of their patient's treatment and outcome tracking, while improving their ability to communicate. Save time, increase productivity, improve communication, and follow patient outcomes.

Myoguide DOC patient management for pain and spasticity and treatment outcome tracking
Myoguide DOC patient management for pain and spasticity and treatment outcome tracking

Intronix Technologies Corp. (http://www.intronixtech.com) is known for producing the Myoguide™ EMG Guided Injection System, which is designed to help clinicians injecting therapeutic Botox like drugs to manage pain and spasticity.  Myoguide works like a Geiger counter generating sound and signal display to help clinicians locate the optimal sites to inject medication to provide relief to their patients.

Myoguide DOC electronic medical record software allows clinicians to take control of their patients by documenting exactly what, where why and how, much medication is injected, on anatomically accurate graphics.  This provides an "at a glance" view of today's injections, as well as being able to show previous treatment encounters, colour coded by date.

Clinicians can select from a collection of existing spasticity syndromes with anatomical graphic panes, or create their own.  A library of pain, spasticity, and capability assessment questionnaires are built in to allow clinicians to assess, and track each patient's state of health over time.  Results are presented in graphical format on each patient's home page.

"Our market research supports DOC will be an essential tool for continuous patient management.  Providing treatment records at a glance, patient outcome tracking, and report writing makes DOC a powerful tool. 

"We are very fortunate for the opportunity to contribute another element to help clinicians who are treating patients suffering from pain and spasticity. Clinicians using DOC will have an easier time seeing how patients are progressing," says Dr. Evan Friedman, President of Intronix Technologies.

Myoguide DOC is a robust, environmentally friendly solution designed for medical practitioners looking to substantially eliminate paper from their practices. DOC can redefine patient care by offering tools with flexibility and scalability for doctor driven workflow that can lead to improved patient care. This simply could not happen in the old paper-based world.

"We are always pushing to innovate and build a better tools. Promoting and supporting innovation in the healthcare software sector is essential to improving patient and community care," said Dr. Friedman. "We will continue working with healthcare providers with vision and integrity, so we can all benefit from a more efficient health care delivery system."

About Intronix Technologies Corporation

Located just outside Toronto, Ontario, Intronix Technologies Corporation designs and produces progressive portable medical devices for neuromuscular diagnostics and treatment delivery.  Its innovations in injection guidance provide technology that drives clinical solutions to deliver confidence, improve workflow efficiency, and provide a better patient experience. Intronix Technologies is known for its innovative equipment, plus comprehensive customer-support programs that are developed to maximize the lifecycle value of equipment through responsive service, maintenance, and significant software support. For additional information about Intronix, please refer to www.intronixtech.com

Contact:
Dr. Evan Friedman
President, Intronix Technologies Corporation
+01-905-951-3361
154585@email4pr.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/patient-pain-management-at-a-glance-300438498.html


'/>"/>
SOURCE Intronix Technologies
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Digital Pharmacist Appoints Kevin Mayes as General Manager & Senior Vice President, Patient Solutions
2. China Proton Therapy Market & Forecast, 2021: Patients Treated at Proton Therapy Facility, Reimbursement Policy 2009-2021 - Research and Markets
3. Global Advanced Remote Patient Monitoring Systems Markets 2012-2021 - Research and Markets
4. Pharmacists Face Challenge of Balancing Patients with Chronic Pain and Opioid Abuse, Misuse
5. Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign - Toilet Talk
6. Medivir Announces Positive Data From the Phase II Study of Remetinostat in Patients With Early-stage Cutaneous T-cell Lymphoma
7. Urgent Care Market Reaches $15 Billion as Locations, Patient Visits Rise
8. Italy Proton Therapy Market, Patients Treated at Proton Therapy Centers & Forecast
9. United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers
10. HLT Announces First Patient Enrollments in a Feasibility Study of a New Transcatheter Aortic Valve Replacement System
11. Boston Childrens Hospital Goes Live With GetWellNetwork for Interactive Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2017)...  Eli Lilly and Company (NYSE: ... Phase 3 MONARCH 2 study showed that abemaciclib, ... combination with fulvestrant, significantly improved progression-free survival (PFS) ... with hormone-receptor-positive (HR+), human epidermal growth factor receptor ... or progressed after endocrine therapy (median PFS, 16.4 ...
(Date:5/30/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will present at the Goldman ... June 13, 2017, in Rancho Palos Verdes, California ... executive officer, is scheduled to present at 3:20 p.m. Pacific ... at http://ir.hill-rom.com/events.cfm . A recorded replay will be available ... 13, 2017. About ...
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
Breaking Medicine Technology:
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating up ... Home and business owners should be aware that the summer months provide more than ... mechanical locks and keys can be negatively affected from direct exposure to the sun. ...
(Date:6/23/2017)... Alexandria, VA (PRWEB) , ... June 23, 2017 ... ... short of what is needed and will ultimately do significant harm to people ... care to everyone. , "While it leaves in place the Affordable Care ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids ... risk of visual loss in these patients. , But how often do ophthalmologists and ... cessation to patients at risk of or with early symptoms of AMD? A ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... Military ... were recently denied entry to the JFK Virgin Atlantic lounge. , Bensko is ... a wheelchair six years ago, Bensko dedicated her life to supporting our wounded veterans. ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Aesthetic Channel has recently ... Talei has come up with a proprietary technique that he calls the AuraLyft ... have dropped. For all ages, patients can expect to look refreshed, rejuvenated, and revitalized. ...
Breaking Medicine News(10 mins):